Inflammatory bowel disease is an umbrella term for chronic conditions that cause ongoing inflammation of the digestive tract, including Crohn’s disease and ulcerative colitis. Together, these conditions affect an estimated 10 million people worldwide. This World IBD Day, recognized on May 19, the Global Remission Coalition calls on health systems to recognize the growing burden of IBD and uplift long-term remission as the central goal of care.
An Overlooked Burden
Ulcerative colitis and Crohn’s disease are both serious, chronic digestive diseases with little general understanding of their cause. For some patients, IBD is mild, but for others it can disrupt every aspect of daily life. People with IBD may experience symptoms such as abdominal pain, diarrhea or bleeding, which carry the serious risk of bowel obstruction, malnutrition, blood clots and colon cancer.
Beyond the physical burden, the impact of IBD can affect emotional, social and financial wellbeing. IBD is a relapsing condition, where patients often cycle between periods of flare-ups and periods of remission. This unpredictability can affect every facet of patients’ lives: work, relationships, family and hobbies.
Prioritizing Timely Care
The longer patients wait to seek treatment, the more damage IBD can cause. Health care providers emphasize the “window of opportunity,” which refers to the early phase after symptoms appear, often within the first two years. Timely diagnosis and treatment during this window can slow disease progression or prevent irreversible damage, giving patients a greater quality of life and peace-of-mind.
Last year, the Global Alliance for Patient Access convened IBD stakeholders across the Asia-Pacific region and they agreed: Proactive management is essential. By investing in early diagnosis, ensuring equitable access to treatment, empowering patients with education and fostering multidisciplinary, patient-centered care, health care systems can help more patients reach sustained remission.
The Value of Remission
Remission should be the goal of IBD care. Remission is more than temporary symptom relief, it can be a long-term outcome, controlling inflammation and preventing long-term complications.
Just as symptoms vary, so does remission, where four types for IBD exist:
- Clinical: Symptoms are reduced or no longer present.
- Biomarker: Inflammatory markers return to healthy levels.
- Endoscopic: Intestinal lining shows visible healing during examination.
- Histologic or Deep Remission: Inflammation is no longer detectable at the microscopic level.
Research finds that achieving remission can reduce hospital visits, lower the risk of surgery and improve long-term outcomes for people living with IBD.
For millions of people around the world, remission represents a measurable goal for a healthier life. This World IBD Day, the Global Remission Coalition urges health systems to prioritize awareness, early diagnosis and improved access to care that ensures all patients can pursue remission.
news
video